文献速递类风湿关节炎

Acod1介导的抑制有氧糖酵解可抑制破骨细胞分化并减轻关节炎中的骨侵蚀

Acod1-mediated inhibition of aerobic glycolysis suppresses osteoclast differentiation and attenuates bone erosion in arthritis.
PubMed 文献 · Ann Rheum Dis · 2024-11-14

该研究探讨Acod1及其代谢物衣康酸在破骨细胞分化和关节炎骨丢失中的作用。RA患者PBMCs中衣康酸水平与疾病活动度呈负相关;Acod1缺陷小鼠在实验性关节炎中破骨细胞数量增多、骨侵蚀加重,而4-OI治疗可减轻炎症性骨丢失并抑制破骨细胞分化。机制上Acod1通过抑制琥珀酸脱氢酶依赖性ROS产生和Hif1α介导的有氧糖酵解 induction 来抑制破骨细胞分化。

要点

  • RA患者PBMCs中衣康酸水平与疾病活动度呈负相关。
  • Acod1缺陷小鼠在实验性关节炎中破骨细胞数量增多、骨侵蚀加重。
  • 4-OI治疗可减轻小鼠炎症性骨丢失并抑制人和小鼠破骨细胞分化。

核心结论

  • Acod1和衣康酸是炎症性关节炎中破骨细胞分化和骨丢失的关键调节因子。

研究设计与样本

  • 研究检测了RA患者和健康对照PBMCs中的衣康酸水平,并在体外用4-OI处理人和小鼠破骨细胞。
  • 研究使用K/BxN血清诱导关节炎小鼠和hTNFtg小鼠,考察Acod1缺陷和4-OI治疗对骨侵蚀的影响。
  • 研究采用SCENITH和细胞外通量分析评估破骨细胞及其前体的代谢活性,通过RNA测序鉴定转录组变化,并用CRISPR/Cas9基因编辑研究Hif1α的作用。

主要发现

  • RA患者PBMCs中衣康酸水平与疾病活动度呈负相关。
  • Acod1缺陷小鼠在实验性关节炎中破骨细胞数量增多、骨侵蚀加重。
  • 4-OI治疗在体内减轻炎症性骨丢失,并在体外抑制人和小鼠破骨细胞分化。
  • Acod1通过抑制琥珀酸脱氢酶依赖性活性氧产生和Hif1α介导的有氧糖酵解 induction 来抑制破骨细胞分化。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Metabolic changes are crucially involved in osteoclast development and may contribute to bone degradation in rheumatoid arthritis (RA). The enzyme aconitate decarboxylase 1 (Acod1) is known to link the cellular function of monocyte-derived macrophages to their metabolic status. As osteoclasts derive from the monocyte lineage, we hypothesised a role for Acod1 and its metabolite itaconate in osteoclast differentiation and arthritis-associated bone loss. METHODS: Itaconate levels were measured in human peripheral blood mononuclear cells (PBMCs) of patients with RA and healthy controls by mass spectrometry. Human and murine osteoclasts were treated with the itaconate derivative 4-octyl-itaconate (4-OI) in vitro. We examined the impact of Acod1-deficiency and 4-OI treatment on bone erosion in mice using K/BxN serum-induced arthritis and human TNF transgenic (hTNFtg) mice. SCENITH and extracellular flux analyses were used to evaluate the metabolic activity of osteoclasts and osteoclast progenitors. Acod1-dependent and itaconate-dependent changes in the osteoclast transcriptome were identified by RNA sequencing. CRISPR/Cas9 gene editing was used to investigate the role of hypoxia-inducible factor (Hif)-1α in Acod1-mediated regulation of osteoclast development. RESULTS: Itaconate levels in PBMCs from patients with RA were inversely correlated with disease activity. Acod1-deficient mice exhibited increased osteoclast numbers and bone erosion in experimental arthritis while 4-OI treatment alleviated inflammatory bone loss in vivo and inhibited human and murine osteoclast differentiation in vitro. Mechanistically, Acod1 suppressed osteoclast differentiation by inhibiting succinate dehydrogenase-dependent production of reactive oxygen species and Hif1α-mediated induction of aerobic glycolysis. CONCLUSION: Acod1 and itaconate are crucial regulators of osteoclast differentiation and bone loss in inflammatory arthritis.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Kachler K, Andreev D, Thapa S, et al. Acod1-mediated inhibition of aerobic glycolysis suppresses osteoclast differentiation and attenuates bone erosion in arthritis. Ann Rheum Dis. 2024. PMID: 38964754. doi:10.1136/ard-2023-224774

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。